MPR Weekly Dose Podcast Episode 26

This week we talk about a phase 1 trial for a potential COVID-19 vaccine that is underway in Seattle; Concerns over COVID-19 and ACE inhibitor, ARB use; Safety labeling changes for SGLT2 inhibitors; A biosimilar to Herceptin; And new graphic warnings for cigarette packages.

COVID-19 Patients May Initially Present With Extrapulmonary Symptoms Such as Diarrhea

Gastrointestinal (GI) symptoms were reported to be the chief complaint in nearly half of patients diagnosed with coronavirus disease 2019 (COVID-19), according to the findings of a cross-sectional study conducted by the Wuhan Medical Treatment Expert Group for COVID-19 in China. The study, which was recently published in The American Journal of Gastroenterology, analyzed data…